title: Paclitaxel-based chemotherapy for advanced pancreatic cancer after gemcitabine-based therapy failure: a case series of 5 patients.
abstract: OBJECTIVE
  Gemcitabine (GEM) is a gold-standard chemotherapy agent for advanced pancreatic cancer. Because of the malignant character of the disease, nearly all patients show disease progression despite treatment with GEM-based chemotherapy; therefore, second-line chemotherapy may be beneficial for these patients. We report a retrospective analysis of 5 patients with advanced pancreatic cancer, treated with a paclitaxel-containing regimen as second-, third- or fourth-line chemotherapy after various therapies, such as a GEM-based regimen, S-1 regimen, and chemoradiation. We retrospectively analyzed the efficacy and adverse events, and evaluated the paclitaxel-containing regimens. A review of the literature is also discussed.
  
  
  RESULTS
  The median overall survival from the start of salvage therapy was 10.7 months. The disease control rate of the paclitaxel-containing regimen according to RECIST criteria was 60%, including complete response in 0 patients, partial response in 3, and stable disease in 2. Two patients had malignant ascites at the start of this salvage therapy, and in both of them the ascites and clinical complaints improved. Grade 3 and 4 hematological adverse events were observed in 2 patients and 1 patient, respectively.
  
  
  CONCLUSIONS
  Salvage paclitaxel-based therapy could be beneficial to advanced pancreatic cancer patients who maintain good performance status after several chemotherapy failures.
authors.affiliation: Department of Medicine and Bioregulatory Science, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan. igaras @ med.kyushu-u.ac.jp
authors.forename: Hisato
authors.initials: H
authors.lastname: Igarashi
authors.forename: Tetsuhide
authors.initials: T
authors.lastname: Ito
authors.forename: Terumasa
authors.initials: T
authors.lastname: Hisano
authors.forename: Nao
authors.initials: N
authors.lastname: Fujimori
authors.forename: Yusuke
authors.initials: Y
authors.lastname: Niina
authors.forename: Mikihiko
authors.initials: M
authors.lastname: Yasuda
authors.forename: Toyoma
authors.initials: T
authors.lastname: Kaku
authors.forename: Susumu
authors.initials: S
authors.lastname: Matsuo
authors.forename: Takamasa
authors.initials: T
authors.lastname: Oono
authors.forename: Masahiro
authors.initials: M
authors.lastname: Yoshinaga
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Sakai
authors.forename: Ryoichi
authors.initials: R
authors.lastname: Takayanagi